{"title":"常见糖尿病药物多药及药物相互作用的数据挖掘方法。","authors":"Jyotsana Dwivedi, Shubhi Kaushal, Pranay Wal, Darshan J C, Ankita Sharma, Deepak Nathiya, Amin Gasmi","doi":"10.2174/0113892002358291250401190533","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>When managing diabetes, polypharmacy the use of several drugs simultaneously to obtain the best possible glucose control is typical. Drug-drug interactions (DDIs), which can result in side effects and reduced treatment efficacy, have increased.</p><p><strong>Objective: </strong>This study evaluated the data mining approach of polypharmacy-based drug-drug interactions for common diabetes medication.</p><p><strong>Methods: </strong>To identify publications that met the inclusion criteria, several scientific reviews and research papers were searched, including Scopus, Web of Science, Google Scholar, PubMed, Science Direct, Springer Link, and NCBI, using keywords such as diabetes, drug-drug interaction, polypharmacy, data mining, and herbal interaction.</p><p><strong>Results: </strong>Many important drug-drug interactions among popular anti-diabetic drugs have been identified using data mining. Using iodinated contrast media and metformin together increased the risk of lactic acidosis, and using NSAIDs and sulfonylureas simultaneously increased the risk of hypoglycemia. A higher incidence of DDIs was found in an analysis of elderly individuals and those with several comorbidities. Predictive models have demonstrated high sensitivity and accuracy in detecting possible DDIs from patient and drug data.</p><p><strong>Conclusion: </strong>Finding and evaluating DDIs in polypharmacy related to diabetes care are made possible through data mining. These results could potentially improve patient safety by influenc-ing more individualized and cautious prescription techniques. The improvement of these methods and their application in standard clinical practice should be the main goal of future studies.</p>","PeriodicalId":10770,"journal":{"name":"Current drug metabolism","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Data Mining Approach on Polypharmacy and Drug-drug Interactions of Common Diabetes Medications.\",\"authors\":\"Jyotsana Dwivedi, Shubhi Kaushal, Pranay Wal, Darshan J C, Ankita Sharma, Deepak Nathiya, Amin Gasmi\",\"doi\":\"10.2174/0113892002358291250401190533\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>When managing diabetes, polypharmacy the use of several drugs simultaneously to obtain the best possible glucose control is typical. Drug-drug interactions (DDIs), which can result in side effects and reduced treatment efficacy, have increased.</p><p><strong>Objective: </strong>This study evaluated the data mining approach of polypharmacy-based drug-drug interactions for common diabetes medication.</p><p><strong>Methods: </strong>To identify publications that met the inclusion criteria, several scientific reviews and research papers were searched, including Scopus, Web of Science, Google Scholar, PubMed, Science Direct, Springer Link, and NCBI, using keywords such as diabetes, drug-drug interaction, polypharmacy, data mining, and herbal interaction.</p><p><strong>Results: </strong>Many important drug-drug interactions among popular anti-diabetic drugs have been identified using data mining. Using iodinated contrast media and metformin together increased the risk of lactic acidosis, and using NSAIDs and sulfonylureas simultaneously increased the risk of hypoglycemia. A higher incidence of DDIs was found in an analysis of elderly individuals and those with several comorbidities. Predictive models have demonstrated high sensitivity and accuracy in detecting possible DDIs from patient and drug data.</p><p><strong>Conclusion: </strong>Finding and evaluating DDIs in polypharmacy related to diabetes care are made possible through data mining. These results could potentially improve patient safety by influenc-ing more individualized and cautious prescription techniques. The improvement of these methods and their application in standard clinical practice should be the main goal of future studies.</p>\",\"PeriodicalId\":10770,\"journal\":{\"name\":\"Current drug metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current drug metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0113892002358291250401190533\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113892002358291250401190533","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:在治疗糖尿病时,多种药物同时使用以获得最佳的血糖控制是典型的。药物-药物相互作用(ddi)可能导致副作用和降低治疗效果,已经增加。目的:评价基于多药药物相互作用的数据挖掘方法在常见糖尿病药物治疗中的应用。方法:检索Scopus、Web of Science、谷歌Scholar、PubMed、Science Direct、施普林格Link、NCBI等多篇科学综述和研究论文,检索关键词为糖尿病、药物相互作用、多药、数据挖掘、草药相互作用等,以确定符合纳入标准的出版物。结果:常用抗糖尿病药物之间的许多重要的药物-药物相互作用已被识别。同时使用碘造影剂和二甲双胍会增加乳酸酸中毒的风险,同时使用非甾体抗炎药和磺脲类药物会增加低血糖的风险。在对老年人和有几种合并症的人群的分析中发现,ddi的发病率较高。预测模型在从患者和药物数据中检测可能的ddi方面显示出很高的灵敏度和准确性。结论:通过数据挖掘,可以发现和评价与糖尿病护理相关的多药DDIs。这些结果可能通过影响更个性化和谨慎的处方技术来潜在地提高患者的安全性。这些方法的改进及其在标准临床实践中的应用应是未来研究的主要目标。
A Data Mining Approach on Polypharmacy and Drug-drug Interactions of Common Diabetes Medications.
Background: When managing diabetes, polypharmacy the use of several drugs simultaneously to obtain the best possible glucose control is typical. Drug-drug interactions (DDIs), which can result in side effects and reduced treatment efficacy, have increased.
Objective: This study evaluated the data mining approach of polypharmacy-based drug-drug interactions for common diabetes medication.
Methods: To identify publications that met the inclusion criteria, several scientific reviews and research papers were searched, including Scopus, Web of Science, Google Scholar, PubMed, Science Direct, Springer Link, and NCBI, using keywords such as diabetes, drug-drug interaction, polypharmacy, data mining, and herbal interaction.
Results: Many important drug-drug interactions among popular anti-diabetic drugs have been identified using data mining. Using iodinated contrast media and metformin together increased the risk of lactic acidosis, and using NSAIDs and sulfonylureas simultaneously increased the risk of hypoglycemia. A higher incidence of DDIs was found in an analysis of elderly individuals and those with several comorbidities. Predictive models have demonstrated high sensitivity and accuracy in detecting possible DDIs from patient and drug data.
Conclusion: Finding and evaluating DDIs in polypharmacy related to diabetes care are made possible through data mining. These results could potentially improve patient safety by influenc-ing more individualized and cautious prescription techniques. The improvement of these methods and their application in standard clinical practice should be the main goal of future studies.
期刊介绍:
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.
More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.